Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Photodynamic Therapy Market

ID: MRFR/HC/41527-HCR
200 Pages
Satyendra Maurya
March 2026

Photodynamic Therapy Market Research Report: Size, Share, Trend Analysis By Applications (Oncology, Dermatology, Cardiology, Dentistry), By Types (Photosensitizing Agents, Light Sources, Lasers), By End Users (Hospitals, Clinics, Research Institutions), By Technology (Laser Phototherapy, Non-Laser Light Phototherapy, PDT with Combination Therapy) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Photodynamic Therapy Market Infographic
Purchase Options

Photodynamic Therapy Market Summary

As per Market Research Future analysis, the Photodynamic Therapy Market Size was estimated at 1.78 USD Billion in 2024. The Photodynamic Therapy industry is projected to grow from 1.974 USD Billion in 2025 to 5.544 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.88% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Photodynamic Therapy Market is poised for substantial growth driven by technological advancements and increasing demand for personalized treatment.

  • Technological advancements in photodynamic therapy are enhancing treatment efficacy and patient outcomes.
  • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector.
  • Oncology is the largest segment, whereas dermatology is witnessing the fastest growth due to rising skin cancer awareness.
  • The rising incidence of cancer and the growing demand for minimally invasive procedures are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 1.78 (USD Billion)
2035 Market Size 5.544 (USD Billion)
CAGR (2025 - 2035) 10.88%

Major Players

Photocure ASA (NO), Galderma S.A. (CH), Merck & Co., Inc. (US), DUSA Pharmaceuticals, Inc. (US), Sensus Healthcare, Inc. (US), Aduro Biotech, Inc. (US), OncoSec Medical Incorporated (US), Curelight Ltd. (IL)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Photodynamic Therapy Market Trends

The Photodynamic Therapy Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing understanding of the therapeutic potential of light-sensitive compounds. This innovative treatment modality, which utilizes light to activate photosensitizing agents, is gaining traction across various medical fields, including oncology, dermatology, and ophthalmology. The growing prevalence of chronic diseases and skin disorders is likely to propel demand for effective and minimally invasive treatment options. Furthermore, ongoing research and development efforts are expected to enhance the efficacy and safety profiles of photodynamic therapy, thereby broadening its application scope. In addition, the Photodynamic Therapy Market is witnessing a shift towards personalized medicine, where treatments are tailored to individual patient needs. This trend is indicative of a broader movement within healthcare, emphasizing the importance of customized therapeutic approaches. As healthcare providers increasingly adopt photodynamic therapy, the integration of advanced imaging techniques and real-time monitoring systems may further optimize treatment outcomes. Overall, the Photodynamic Therapy Market appears poised for growth, with a focus on innovation and patient-centered care likely to shape its future trajectory.

Technological Advancements

Recent innovations in light delivery systems and photosensitizers are enhancing the effectiveness of photodynamic therapy. These advancements may lead to improved treatment outcomes and expanded applications in various medical fields.

Personalized Treatment Approaches

The trend towards personalized medicine is influencing the Photodynamic Therapy Market, as healthcare providers seek to tailor treatments to individual patient profiles. This shift could enhance therapeutic efficacy and patient satisfaction.

Increased Awareness and Acceptance

Growing awareness among healthcare professionals and patients regarding the benefits of photodynamic therapy is likely to drive market growth. As acceptance increases, more practitioners may incorporate this modality into their treatment regimens.

Photodynamic Therapy Market Drivers

Rising Incidence of Cancer

The increasing prevalence of cancer worldwide is a primary driver for the Photodynamic Therapy Market. As cancer cases rise, the demand for effective treatment options escalates. According to recent statistics, cancer is projected to affect millions annually, leading to a surge in the need for innovative therapies. Photodynamic therapy, known for its targeted approach and minimal side effects, is gaining traction among healthcare providers. This trend is likely to continue, as patients and practitioners seek alternatives to traditional treatments. The Photodynamic Therapy Market is expected to expand significantly, driven by the urgent need for effective cancer management solutions.

Regulatory Support and Approval

Regulatory bodies are increasingly recognizing the potential of photodynamic therapy, which is fostering growth in the Photodynamic Therapy Market. Recent approvals of new photodynamic agents and treatment protocols by health authorities indicate a supportive regulatory environment. This trend encourages manufacturers to invest in the development of novel therapies, knowing that there is a pathway for approval. Furthermore, favorable reimbursement policies for photodynamic therapy treatments are likely to enhance accessibility for patients. As regulatory support continues to strengthen, the Photodynamic Therapy Market is expected to flourish.

Increased Research and Development Activities

The surge in research and development activities within the medical field is a notable driver for the Photodynamic Therapy Market. Numerous studies are being conducted to explore the potential applications of photodynamic therapy beyond oncology, including dermatology and ophthalmology. This expansion into new therapeutic areas could broaden the market's scope and attract a diverse patient population. Additionally, funding from governmental and private sectors for innovative treatment research is likely to enhance the development of new photodynamic agents and techniques. As R&D efforts intensify, the Photodynamic Therapy Market may experience accelerated growth.

Growing Demand for Minimally Invasive Procedures

The shift towards minimally invasive treatment options is significantly influencing the Photodynamic Therapy Market. Patients increasingly prefer therapies that offer reduced recovery times and lower risks of complications. Photodynamic therapy aligns with this trend, as it typically involves less invasive procedures compared to traditional surgical methods. This preference is reflected in patient choices and healthcare provider recommendations, leading to a rise in the adoption of photodynamic therapy for various conditions. As awareness of the benefits of minimally invasive treatments continues to grow, the Photodynamic Therapy Market is poised for substantial growth.

Technological Innovations in Photodynamic Therapy

Technological advancements play a crucial role in shaping the Photodynamic Therapy Market. Innovations in light delivery systems, photosensitizers, and imaging techniques enhance the efficacy and safety of photodynamic therapy. For instance, the development of new photosensitizers that are more effective at lower doses could potentially improve patient outcomes. Furthermore, advancements in laser technology allow for more precise targeting of tumors, minimizing damage to surrounding healthy tissues. As these technologies evolve, they are likely to attract more investment and research, thereby propelling the growth of the Photodynamic Therapy Market.

Market Segment Insights

By Application: Oncology (Largest) vs. Dermatology (Fastest-Growing)

The Photodynamic Therapy Market is significantly influenced by its application segments, notably Oncology, Dermatology, Cardiology, and Dentistry. Oncology holds the largest share, leveraging advanced light-based therapies for cancer treatment, which showcases its established presence and trusted efficacy. Meanwhile, Dermatology follows with considerable prominence, employing photodynamic therapy for skin conditions like acne, actinic keratosis, and basal cell carcinoma, thus capturing substantial market interest.

Oncology (Dominant) vs. Dermatology (Emerging)

Oncology remains the dominant segment in the Photodynamic Therapy Market, characterized by its comprehensive use in treating various cancers through targeted light-activated drugs. The therapies are favored for their precision, minimizing damage to surrounding healthy tissues and maximizing treatment efficacy. Conversely, Dermatology is emerging rapidly, driven by increasing awareness and acceptance of photodynamic treatments for skin disorders. The segment's growth is bolstered by innovations in light delivery systems and novel photosensitizers, enhancing patient outcomes and leading to a broader adoption of these therapies in both clinical and cosmetic practices.

By Type of Photosensitizer: Porphyrins (Largest) vs. Synthetic Dyes (Fastest-Growing)

The photodynamic therapy market showcases a diverse array of photosensitizers, with porphyrins leading the way as the most significant segment due to their extensive application and efficacy in cancer treatment. This segment benefits from established research and numerous clinical applications, making porphyrins a preferred choice for therapeutic procedures. In contrast, synthetic dyes are becoming more prevalent, capturing the attention of researchers and practitioners alike due to their enhanced absorption properties and tunable chemical structures that allow for novel treatment strategies.

Porphyrins (Dominant) vs. Synthetic Dyes (Emerging)

Porphyrins remain the dominant type of photosensitizer in photodynamic therapy, recognized for their effectiveness in targeting malignant tissues and minimizing damage to surrounding healthy cells. Their structure supports optimal light absorption and generation of reactive oxygen species, essential for therapeutic efficacy. On the other hand, synthetic dyes represent an emerging alternative, driven by advancements in synthesis techniques that yield dyes with specific absorption characteristics. This provides flexibility in application and expands treatment possibilities, appealing particularly in niche markets where custom-tailored therapies are required. As research continues to explore new synthetic dye formulations, this segment's growth potential remains substantial.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The photodynamic therapy market is experiencing a diverse distribution across various end-user segments. Hospitals remain the largest segment due to their comprehensive capabilities in providing advanced therapeutic solutions. Ambulatory Surgical Centers (ASCs) are also gaining traction, appealing to patients seeking less invasive procedures. Specialty Clinics and Research Institutions have their respective shares, creating a competitive landscape, while Home Care Settings are becoming increasingly relevant due to rising demand for at-home treatment options.

Hospitals: Dominant vs. Ambulatory Surgical Centers: Emerging

Hospitals are the dominant end-user of photodynamic therapy, leveraging their extensive infrastructure and expertise in offering a full range of treatment options. They serve as critical care centers, enabling sophisticated therapies that require access to specialized equipment and trained personnel. Meanwhile, Ambulatory Surgical Centers are emerging rapidly in this market, providing convenience and lower costs, which attract patients seeking outpatient care and quicker recovery times. This trend towards ASCs is driven by patient preference for less invasive treatments and the growing focus on improving healthcare accessibility.

By Technology: Laser Phototherapy (Largest) vs. Non-Laser Light Phototherapy (Fastest-Growing)

The Photodynamic Therapy Market is notably segmented by technology, with Laser Phototherapy dominating the market. This segment has established itself as a trusted modality in various applications, making it the largest contributor to market share. Its precision and efficacy in targeting tissues with minimal damage have propelled its widespread adoption and recognition among healthcare professionals. In contrast, Non-Laser Light Phototherapy is gaining momentum, appealing to a newer demographic drawn to its versatile applications and non-invasive nature. This segment has witnessed accelerated uptake, reflecting the evolving preferences of patients seeking alternative treatment modalities. Growth trends in the Photodynamic Therapy Market reveal that advancements in technology and increased awareness about phototherapy have stimulated an upward growth trajectory. The rise in chronic conditions requiring effective therapeutic solutions has also contributed significantly to market expansion. Healthcare professionals are increasingly incorporating both Laser and Non-Laser light modalities into treatment protocols, driven by favorable patient outcomes. The focus on research and development for new treatments presents robust opportunities for further growth amid changing healthcare dynamics.

Technology: Laser Phototherapy (Dominant) vs. Non-Laser Light Phototherapy (Emerging)

Laser Phototherapy stands as the dominant technology in the Photodynamic Therapy Market, characterized by its precision in delivering light energy and its authority in treating conditions like cancer and skin disorders. The high efficacy and targeted nature of laser systems ensure minimal collateral damage, bolstering clinician confidence and patient outcomes. Meanwhile, Non-Laser Light Phototherapy is quickly emerging, known for its accessibility and adaptability across diverse treatments. This segment appeals to a broad audience, including those deterred by invasive procedures. Its continued development and increasing recognition among practitioners signify a growing inclination towards its integration into treatment paradigms, thus reshaping the competitive landscape of the market.

Get more detailed insights about Photodynamic Therapy Market

Regional Insights

North America holds a significant portion, valued at 0.75 USD Billion, and is projected to dominate with an expected value of 2.35 USD Billion in 2035, driven by advanced healthcare infrastructure and high adoption of innovative therapies. Europe follows with a valuation of 0.5 USD Billion in 2024, anticipated to reach 1.6 USD Billion by 2035, reflecting a robust market growth fueled by increased awareness and technological advancements.

The APAC region, valued at 0.4 USD Billion in 2024 and expected to grow to 1.25 USD Billion by 2035, is becoming increasingly important due to rising demand for cost-effective treatment options and improved healthcare access. South America and MEA, while smaller markets valued at 0.08 USD Billion and 0.05 USD Billion respectively in 2024 are poised for growth as healthcare systems evolve and access to treatments expands, though they currently contribute less to the overall market.

The competitive landscape and market growth are significantly influenced by the varying healthcare policies, economic conditions, and uptake of photodynamic therapy advancements across these regions.

Photodynamic Therapy Market Regional Image

Key Players and Competitive Insights

The Global Photodynamic Therapy Market has demonstrated robust growth driven by advancements in technology, increasing healthcare expenditures, and an expanding range of applications in treating various conditions including cancer, macular degeneration and skin disorders. As more healthcare providers adopt photodynamic therapy due to its minimally invasive nature and effective treatment outcomes, competition among players in this sector has intensified. Companies are strategically positioning themselves by innovating product pipelines, forming partnerships, and enhancing their distribution networks to capture market share. The increasing prevalence of chronic diseases and the rising demand for outpatient therapies further contribute to the competitive dynamics that define this evolving market landscape. Lumenis stands out in the Global Photodynamic Therapy Market by leveraging its strong technological capabilities and a diverse portfolio of advanced systems that utilize precisely controlled light for therapeutic purposes. Known for its extensive experience and expertise in energy-based technologies, Lumenis has established a significant presence, particularly in non-invasive treatments. The company’s commitment to research and development is noteworthy, as it continuously innovates its offerings to integrate new features that enhance treatment effectiveness and patient safety. With a strong focus on clinical data and user feedback, Lumenis maintains its competitive advantage by ensuring its products meet the rigorous demands of healthcare providers and patients alike. ConvaTec has made substantial contributions within the Global Photodynamic Therapy Market, focusing on developing innovative solutions that cater to specific therapeutic needs. The company emphasizes a patient-centered approach, concentrating on improving treatment outcomes and enhancing patient quality of life. ConvaTec’s product development is characterized by strategic initiatives aimed at combining advanced technology with practical application to address market gaps. Their strong reputation in medical devices, combined with robust regulatory compliance and quality management systems, positions ConvaTec favorably in the competitive landscape. By fostering collaborations with healthcare professionals and institutions, the company aims to expand its market reach and reinforce its presence in the photodynamic therapy segment.

Key Companies in the Photodynamic Therapy Market include

Industry Developments

  • Q2 2024: Biofrontera Inc. Announces FDA Approval of Ameluz® for Expanded Indication in Photodynamic Therapy Market Biofrontera Inc. received FDA approval to expand the indication of its Ameluz® gel for use in photodynamic therapy, allowing treatment of actinic keratosis on the extremities and trunk in addition to the face and scalp.
  • Q2 2024: Lumeda Announces $6 Million Series A Financing to Advance Photodynamic Therapy Market Platform Lumeda, a company developing next-generation photodynamic therapy solutions for lung cancer, closed a $6 million Series A funding round to support clinical development and commercialization efforts.
  • Q2 2024: Soligenix Announces Positive Results from Phase 3 FLASH Study of SGX301 in Cutaneous T-Cell Lymphoma Soligenix reported positive topline results from its Phase 3 FLASH study evaluating SGX301, a novel photodynamic therapy, for the treatment of cutaneous T-cell lymphoma, supporting a future regulatory submission.
  • Q3 2024: Biofrontera Inc. Appoints New Chief Executive Officer Biofrontera Inc., a key player in the photodynamic therapy market, announced the appointment of a new CEO to lead the company’s next phase of growth and product expansion.
  • Q3 2024: Lumeda and Mayo Clinic Announce Strategic Collaboration to Advance Photodynamic Therapy Market for Lung Cancer Lumeda entered into a strategic collaboration with Mayo Clinic to accelerate the development and clinical validation of its photodynamic therapy platform for lung cancer treatment.
  • Q4 2024: Biofrontera Inc. Opens New Manufacturing Facility in the United States Biofrontera Inc. inaugurated a new manufacturing facility in the U.S. to increase production capacity for its photodynamic therapy products, supporting growing demand in North America.
  • Q1 2025: Soligenix Submits New Drug Application to FDA for SGX301 in Cutaneous T-Cell Lymphoma Soligenix submitted a New Drug Application to the FDA for SGX301, seeking approval for its photodynamic therapy in the treatment of cutaneous T-cell lymphoma.
  • Q1 2025: Lumeda Receives Breakthrough Device Designation from FDA for Photodynamic Therapy Market System Lumeda was granted Breakthrough Device Designation by the FDA for its photodynamic therapy system, designed to improve outcomes in lung cancer patients.
  • Q2 2025: Biofrontera Inc. Announces Partnership with Cardinal Health for U.S. Distribution of Ameluz® Biofrontera Inc. entered into a distribution agreement with Cardinal Health to expand the reach of its Ameluz® photodynamic therapy gel across the United States.
  • Q2 2025: Soligenix Receives European Medicines Agency Orphan Drug Designation for SGX301 Soligenix was granted Orphan Drug Designation by the European Medicines Agency for SGX301, its photodynamic therapy candidate for cutaneous T-cell lymphoma.

Future Outlook

Photodynamic Therapy Market Future Outlook

The Photodynamic Therapy Market is projected to grow at a 10.88% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure.

New opportunities lie in:

  • Development of targeted photodynamic agents for specific cancer types.
  • Expansion of telemedicine platforms for remote photodynamic therapy consultations.
  • Partnerships with healthcare providers for integrated photodynamic therapy services.

By 2035, the Photodynamic Therapy Market is expected to achieve substantial growth and innovation.

Market Segmentation

Photodynamic Therapy Market Type Outlook

  • Photosensitizing Agents
  • Light Sources
  • Lasers

Photodynamic Therapy Market End User Outlook

  • Hospitals
  • Clinics
  • Research Institutions

Photodynamic Therapy Market Technology Outlook

  • Laser Phototherapy
  • Non-Laser Light Phototherapy
  • PDT with Combination Therapy

Photodynamic Therapy Market Application Outlook

  • Oncology
  • Dermatology
  • Cardiology
  • Dentistry

Report Scope

MARKET SIZE 2024 1.78(USD Billion)
MARKET SIZE 2025 1.974(USD Billion)
MARKET SIZE 2035 5.544(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 10.88% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Photocure ASA (NO), Galderma S.A. (CH), Merck & Co., Inc. (US), DUSA Pharmaceuticals, Inc. (US), Sensus Healthcare, Inc. (US), Aduro Biotech, Inc. (US), OncoSec Medical Incorporated (US), Curelight Ltd. (IL)
Segments Covered Applications, Types, End Users, Technology, Regional
Key Market Opportunities Advancements in light-activated agents enhance efficacy in the Photodynamic Therapy Market.
Key Market Dynamics Rising demand for minimally invasive treatments drives innovation and competition in the Photodynamic Therapy Market.
Countries Covered North America, Europe, APAC, South America, MEA
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Leave a Comment

FAQs

What is the current market valuation of the photodynamic therapy market?

<p>As of 2024, the photodynamic therapy market was valued at 0.77 USD Billion.</p>

What is the projected market size for photodynamic therapy by 2035?

<p>The market is expected to reach a valuation of 1.27 USD Billion by 2035.</p>

What is the expected CAGR for the photodynamic therapy market during the forecast period?

<p>The photodynamic therapy market is projected to grow at a CAGR of 4.65% from 2025 to 2035.</p>

Which applications dominate the photodynamic therapy market?

<p>In 2024, oncology led the market with a valuation of 0.3 USD Billion, followed by dermatology at 0.15 USD Billion.</p>

What types of photosensitizers are utilized in photodynamic therapy?

<p>Porphyrins accounted for 0.25 USD Billion in 2024, making them the most utilized type of photosensitizer.</p>

Who are the key players in the photodynamic therapy market?

<p>Key players include Photocure ASA, Galderma S.A., and Merck KGaA, among others.</p>

What are the primary end users of photodynamic therapy?

<p>Hospitals represented a significant segment, valued at 0.25 USD Billion in 2024.</p>

How does the photodynamic therapy market perform in the ophthalmology segment?

<p>The ophthalmology segment was valued at 0.1 USD Billion in 2024, indicating its emerging role in the market.</p>

What is the market valuation for photodynamic therapy in home care settings?

<p>In 2024, home care settings accounted for a valuation of 0.17 USD Billion.</p>

What trends are anticipated for the photodynamic therapy market in the coming years?

<p>The market is likely to experience growth driven by advancements in technology and increasing applications across various medical fields.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions